Methionine EP Impurity D

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB1879009967
CAS	1879009-96-7
Molecular Weight	322.44
Molecular Formula	C12H22N2O4S2

What is the name of the impurity indicated by CAS number 1879009-96-7?

The impurity is Methionine EP Impurity D.

What is the molecular weight of Methionine EP Impurity D?

The molecular weight is 322.44 g/mol.

What is the molecular formula of Methionine EP Impurity D?

The molecular formula is C12H22N2O4S2.

How does Methionine EP Impurity D differ from pure Methionine in terms of molecular structure?

Methionine EP Impurity D has additional elements in its molecular structure that are not present in pure Methionine.

What is the significance of identifying Methionine EP Impurity D in pharmaceutical products?

Identifying impurities like Methionine EP Impurity D is important for quality control and ensuring the safety and efficacy of pharmaceutical products.

Are there specific regulations or guidelines that pharmaceutical companies must follow regarding the presence of Methionine EP Impurity D?

Yes, the European Pharmacopoeia sets standards for the identification and control of impurities like Methionine EP Impurity D in pharmaceutical products.

How might the presence of Methionine EP Impurity D impact the stability or shelf life of a pharmaceutical product?

The presence of impurities like Methionine EP Impurity D can affect the stability and shelf life of a pharmaceutical product, potentially leading to degradation or reduced efficacy.

What analytical techniques are commonly used to detect and quantify impurities like Methionine EP Impurity D in pharmaceutical products?

Techniques like high-performance liquid chromatography (HPLC) and mass spectrometry are often used to analyze and quantify impurities in pharmaceutical products.

Can Methionine EP Impurity D be harmful if present in high concentrations in pharmaceutical products?

Yes, impurities like Methionine EP Impurity D can be harmful if present in high concentrations, potentially leading to adverse effects on patient health.

What steps can pharmaceutical companies take to minimize the presence of Methionine EP Impurity D in their products?

Pharmaceutical companies can implement rigorous quality control measures, such as strict testing protocols and adherence to regulatory guidelines, to minimize the presence of impurities like Methionine EP Impurity D in their products.

* Products or Services Interested: Methionine EP Impurity D (1879009-96-7)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry